Clinical impact of COVID-19 in a single-center cohort of a prospective study in cancer patients receiving immunotherapy.
Identifieur interne : 000204 ( Main/Corpus ); précédent : 000203; suivant : 000205Clinical impact of COVID-19 in a single-center cohort of a prospective study in cancer patients receiving immunotherapy.
Auteurs : Melissa Bersanelli ; Teresa Zielli ; Fabiana Perrone ; Chiara Casartelli ; Fabiana Prattic ; Elena Rapacchi ; Roberta Camisa ; Michele Tognetto ; Alberto Clemente ; Diana Giannarelli ; Sara Elena Rebuzzi ; Alessandro Leonetti ; Paola Bordi ; Marcello Tiseo ; Sebastiano ButiSource :
- Immunotherapy [ 1750-7448 ] ; 2020.
English descriptors
- KwdEn :
- Adult (MeSH), Aged (MeSH), Aged, 80 and over (MeSH), Antineoplastic Agents, Immunological (therapeutic use), Betacoronavirus (isolation & purification), Coronavirus Infections (diagnosis), Coronavirus Infections (epidemiology), Coronavirus Infections (pathology), Coronavirus Infections (physiopathology), Female (MeSH), Humans (MeSH), Immunotherapy (MeSH), Incidence (MeSH), Italy (epidemiology), Lung (diagnostic imaging), Lung (pathology), Male (MeSH), Middle Aged (MeSH), Neoplasms (epidemiology), Neoplasms (therapy), Pandemics (MeSH), Pharynx (virology), Pneumonia, Viral (diagnosis), Pneumonia, Viral (epidemiology), Pneumonia, Viral (pathology), Pneumonia, Viral (physiopathology), Prospective Studies (MeSH), Risk Factors (MeSH), Tomography, X-Ray Computed (MeSH).
- MESH :
- chemical , therapeutic use : Antineoplastic Agents, Immunological.
- geographic , epidemiology : Italy.
- diagnosis : Coronavirus Infections, Pneumonia, Viral.
- diagnostic imaging : Lung.
- epidemiology : Coronavirus Infections, Neoplasms, Pneumonia, Viral.
- isolation & purification : Betacoronavirus.
- pathology : Coronavirus Infections, Lung, Pneumonia, Viral.
- physiopathology : Coronavirus Infections, Pneumonia, Viral.
- therapy : Neoplasms.
- virology : Pharynx.
- Adult, Aged, Aged, 80 and over, Female, Humans, Immunotherapy, Incidence, Male, Middle Aged, Pandemics, Prospective Studies, Risk Factors, Tomography, X-Ray Computed.
Abstract
Aim: Evaluating the incidence and course of COVID-19 in cancer patients treated with immunotherapy. Patients & methods: We reported the influenza-like illness events with diagnosis of COVID-19 within the patient cohort enrolled in the prospective observational multicenter INVIDIa-2 study in the single center of Parma. Results: Among 53 patients, eight experienced influenza-like illness during the influenza season 2019/2020, and three of them had diagnosis of COVID-19. They were males, elderly, with cardiovascular disease. Radiological features of COVID-19 pneumonitis were found in all of three cases, although the pharyngeal swab resulted positive in only two. Two of these three patients died due to respiratory failure. Conclusion: Cancer patients are at high risk of severe events from severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection.
DOI: 10.2217/imt-2020-0211
PubMed: 32933369
PubMed Central: PMC7493722
Links to Exploration step
pubmed:32933369Le document en format XML
<record><TEI><teiHeader><fileDesc><titleStmt><title xml:lang="en">Clinical impact of COVID-19 in a single-center cohort of a prospective study in cancer patients receiving immunotherapy.</title>
<author><name sortKey="Bersanelli, Melissa" sort="Bersanelli, Melissa" uniqKey="Bersanelli M" first="Melissa" last="Bersanelli">Melissa Bersanelli</name>
<affiliation><nlm:affiliation>Medical Oncology Unit, University of Parma, 43126, Parma, Italy.</nlm:affiliation>
</affiliation>
<affiliation><nlm:affiliation>Medicine & Surgery Department, University of Parma, Parma, Italy.</nlm:affiliation>
</affiliation>
</author>
<author><name sortKey="Zielli, Teresa" sort="Zielli, Teresa" uniqKey="Zielli T" first="Teresa" last="Zielli">Teresa Zielli</name>
<affiliation><nlm:affiliation>Medical Oncology Unit, University of Parma, 43126, Parma, Italy.</nlm:affiliation>
</affiliation>
</author>
<author><name sortKey="Perrone, Fabiana" sort="Perrone, Fabiana" uniqKey="Perrone F" first="Fabiana" last="Perrone">Fabiana Perrone</name>
<affiliation><nlm:affiliation>Medical Oncology Unit, University of Parma, 43126, Parma, Italy.</nlm:affiliation>
</affiliation>
</author>
<author><name sortKey="Casartelli, Chiara" sort="Casartelli, Chiara" uniqKey="Casartelli C" first="Chiara" last="Casartelli">Chiara Casartelli</name>
<affiliation><nlm:affiliation>Medical Oncology Unit, University of Parma, 43126, Parma, Italy.</nlm:affiliation>
</affiliation>
</author>
<author><name sortKey="Prattic, Fabiana" sort="Prattic, Fabiana" uniqKey="Prattic F" first="Fabiana" last="Prattic">Fabiana Prattic</name>
<affiliation><nlm:affiliation>Medicine & Surgery Department, University of Parma, Parma, Italy.</nlm:affiliation>
</affiliation>
</author>
<author><name sortKey="Rapacchi, Elena" sort="Rapacchi, Elena" uniqKey="Rapacchi E" first="Elena" last="Rapacchi">Elena Rapacchi</name>
<affiliation><nlm:affiliation>Medical Oncology Unit, University of Parma, 43126, Parma, Italy.</nlm:affiliation>
</affiliation>
</author>
<author><name sortKey="Camisa, Roberta" sort="Camisa, Roberta" uniqKey="Camisa R" first="Roberta" last="Camisa">Roberta Camisa</name>
<affiliation><nlm:affiliation>Medical Oncology Unit, University of Parma, 43126, Parma, Italy.</nlm:affiliation>
</affiliation>
</author>
<author><name sortKey="Tognetto, Michele" sort="Tognetto, Michele" uniqKey="Tognetto M" first="Michele" last="Tognetto">Michele Tognetto</name>
<affiliation><nlm:affiliation>Medical Oncology Unit, University of Parma, 43126, Parma, Italy.</nlm:affiliation>
</affiliation>
</author>
<author><name sortKey="Clemente, Alberto" sort="Clemente, Alberto" uniqKey="Clemente A" first="Alberto" last="Clemente">Alberto Clemente</name>
<affiliation><nlm:affiliation>Biostatistics & Clinical Research Unit, Istituto Scientifico Romagnolo per lo Studio e la Cura dei Tumori (IRST) IRCCS, 47014, Meldola, Italy.</nlm:affiliation>
</affiliation>
</author>
<author><name sortKey="Giannarelli, Diana" sort="Giannarelli, Diana" uniqKey="Giannarelli D" first="Diana" last="Giannarelli">Diana Giannarelli</name>
<affiliation><nlm:affiliation>Biostatistical Unit, Regina Elena National Cancer Institute, IRCCS, 00144, Rome, Italy.</nlm:affiliation>
</affiliation>
</author>
<author><name sortKey="Rebuzzi, Sara Elena" sort="Rebuzzi, Sara Elena" uniqKey="Rebuzzi S" first="Sara Elena" last="Rebuzzi">Sara Elena Rebuzzi</name>
<affiliation><nlm:affiliation>Medical Oncology Unit, University of Parma, 43126, Parma, Italy.</nlm:affiliation>
</affiliation>
</author>
<author><name sortKey="Leonetti, Alessandro" sort="Leonetti, Alessandro" uniqKey="Leonetti A" first="Alessandro" last="Leonetti">Alessandro Leonetti</name>
<affiliation><nlm:affiliation>Medical Oncology Unit, University of Parma, 43126, Parma, Italy.</nlm:affiliation>
</affiliation>
<affiliation><nlm:affiliation>Medicine & Surgery Department, University of Parma, Parma, Italy.</nlm:affiliation>
</affiliation>
</author>
<author><name sortKey="Bordi, Paola" sort="Bordi, Paola" uniqKey="Bordi P" first="Paola" last="Bordi">Paola Bordi</name>
<affiliation><nlm:affiliation>Medical Oncology Unit, University of Parma, 43126, Parma, Italy.</nlm:affiliation>
</affiliation>
</author>
<author><name sortKey="Tiseo, Marcello" sort="Tiseo, Marcello" uniqKey="Tiseo M" first="Marcello" last="Tiseo">Marcello Tiseo</name>
<affiliation><nlm:affiliation>Medicine & Surgery Department, University of Parma, Parma, Italy.</nlm:affiliation>
</affiliation>
</author>
<author><name sortKey="Buti, Sebastiano" sort="Buti, Sebastiano" uniqKey="Buti S" first="Sebastiano" last="Buti">Sebastiano Buti</name>
<affiliation><nlm:affiliation>Medical Oncology Unit, University of Parma, 43126, Parma, Italy.</nlm:affiliation>
</affiliation>
</author>
</titleStmt>
<publicationStmt><idno type="wicri:source">PubMed</idno>
<date when="2020">2020</date>
<idno type="RBID">pubmed:32933369</idno>
<idno type="pmid">32933369</idno>
<idno type="doi">10.2217/imt-2020-0211</idno>
<idno type="pmc">PMC7493722</idno>
<idno type="wicri:Area/Main/Corpus">000204</idno>
<idno type="wicri:explorRef" wicri:stream="Main" wicri:step="Corpus" wicri:corpus="PubMed">000204</idno>
</publicationStmt>
<sourceDesc><biblStruct><analytic><title xml:lang="en">Clinical impact of COVID-19 in a single-center cohort of a prospective study in cancer patients receiving immunotherapy.</title>
<author><name sortKey="Bersanelli, Melissa" sort="Bersanelli, Melissa" uniqKey="Bersanelli M" first="Melissa" last="Bersanelli">Melissa Bersanelli</name>
<affiliation><nlm:affiliation>Medical Oncology Unit, University of Parma, 43126, Parma, Italy.</nlm:affiliation>
</affiliation>
<affiliation><nlm:affiliation>Medicine & Surgery Department, University of Parma, Parma, Italy.</nlm:affiliation>
</affiliation>
</author>
<author><name sortKey="Zielli, Teresa" sort="Zielli, Teresa" uniqKey="Zielli T" first="Teresa" last="Zielli">Teresa Zielli</name>
<affiliation><nlm:affiliation>Medical Oncology Unit, University of Parma, 43126, Parma, Italy.</nlm:affiliation>
</affiliation>
</author>
<author><name sortKey="Perrone, Fabiana" sort="Perrone, Fabiana" uniqKey="Perrone F" first="Fabiana" last="Perrone">Fabiana Perrone</name>
<affiliation><nlm:affiliation>Medical Oncology Unit, University of Parma, 43126, Parma, Italy.</nlm:affiliation>
</affiliation>
</author>
<author><name sortKey="Casartelli, Chiara" sort="Casartelli, Chiara" uniqKey="Casartelli C" first="Chiara" last="Casartelli">Chiara Casartelli</name>
<affiliation><nlm:affiliation>Medical Oncology Unit, University of Parma, 43126, Parma, Italy.</nlm:affiliation>
</affiliation>
</author>
<author><name sortKey="Prattic, Fabiana" sort="Prattic, Fabiana" uniqKey="Prattic F" first="Fabiana" last="Prattic">Fabiana Prattic</name>
<affiliation><nlm:affiliation>Medicine & Surgery Department, University of Parma, Parma, Italy.</nlm:affiliation>
</affiliation>
</author>
<author><name sortKey="Rapacchi, Elena" sort="Rapacchi, Elena" uniqKey="Rapacchi E" first="Elena" last="Rapacchi">Elena Rapacchi</name>
<affiliation><nlm:affiliation>Medical Oncology Unit, University of Parma, 43126, Parma, Italy.</nlm:affiliation>
</affiliation>
</author>
<author><name sortKey="Camisa, Roberta" sort="Camisa, Roberta" uniqKey="Camisa R" first="Roberta" last="Camisa">Roberta Camisa</name>
<affiliation><nlm:affiliation>Medical Oncology Unit, University of Parma, 43126, Parma, Italy.</nlm:affiliation>
</affiliation>
</author>
<author><name sortKey="Tognetto, Michele" sort="Tognetto, Michele" uniqKey="Tognetto M" first="Michele" last="Tognetto">Michele Tognetto</name>
<affiliation><nlm:affiliation>Medical Oncology Unit, University of Parma, 43126, Parma, Italy.</nlm:affiliation>
</affiliation>
</author>
<author><name sortKey="Clemente, Alberto" sort="Clemente, Alberto" uniqKey="Clemente A" first="Alberto" last="Clemente">Alberto Clemente</name>
<affiliation><nlm:affiliation>Biostatistics & Clinical Research Unit, Istituto Scientifico Romagnolo per lo Studio e la Cura dei Tumori (IRST) IRCCS, 47014, Meldola, Italy.</nlm:affiliation>
</affiliation>
</author>
<author><name sortKey="Giannarelli, Diana" sort="Giannarelli, Diana" uniqKey="Giannarelli D" first="Diana" last="Giannarelli">Diana Giannarelli</name>
<affiliation><nlm:affiliation>Biostatistical Unit, Regina Elena National Cancer Institute, IRCCS, 00144, Rome, Italy.</nlm:affiliation>
</affiliation>
</author>
<author><name sortKey="Rebuzzi, Sara Elena" sort="Rebuzzi, Sara Elena" uniqKey="Rebuzzi S" first="Sara Elena" last="Rebuzzi">Sara Elena Rebuzzi</name>
<affiliation><nlm:affiliation>Medical Oncology Unit, University of Parma, 43126, Parma, Italy.</nlm:affiliation>
</affiliation>
</author>
<author><name sortKey="Leonetti, Alessandro" sort="Leonetti, Alessandro" uniqKey="Leonetti A" first="Alessandro" last="Leonetti">Alessandro Leonetti</name>
<affiliation><nlm:affiliation>Medical Oncology Unit, University of Parma, 43126, Parma, Italy.</nlm:affiliation>
</affiliation>
<affiliation><nlm:affiliation>Medicine & Surgery Department, University of Parma, Parma, Italy.</nlm:affiliation>
</affiliation>
</author>
<author><name sortKey="Bordi, Paola" sort="Bordi, Paola" uniqKey="Bordi P" first="Paola" last="Bordi">Paola Bordi</name>
<affiliation><nlm:affiliation>Medical Oncology Unit, University of Parma, 43126, Parma, Italy.</nlm:affiliation>
</affiliation>
</author>
<author><name sortKey="Tiseo, Marcello" sort="Tiseo, Marcello" uniqKey="Tiseo M" first="Marcello" last="Tiseo">Marcello Tiseo</name>
<affiliation><nlm:affiliation>Medicine & Surgery Department, University of Parma, Parma, Italy.</nlm:affiliation>
</affiliation>
</author>
<author><name sortKey="Buti, Sebastiano" sort="Buti, Sebastiano" uniqKey="Buti S" first="Sebastiano" last="Buti">Sebastiano Buti</name>
<affiliation><nlm:affiliation>Medical Oncology Unit, University of Parma, 43126, Parma, Italy.</nlm:affiliation>
</affiliation>
</author>
</analytic>
<series><title level="j">Immunotherapy</title>
<idno type="eISSN">1750-7448</idno>
<imprint><date when="2020" type="published">2020</date>
</imprint>
</series>
</biblStruct>
</sourceDesc>
</fileDesc>
<profileDesc><textClass><keywords scheme="KwdEn" xml:lang="en"><term>Adult (MeSH)</term>
<term>Aged (MeSH)</term>
<term>Aged, 80 and over (MeSH)</term>
<term>Antineoplastic Agents, Immunological (therapeutic use)</term>
<term>Betacoronavirus (isolation & purification)</term>
<term>Coronavirus Infections (diagnosis)</term>
<term>Coronavirus Infections (epidemiology)</term>
<term>Coronavirus Infections (pathology)</term>
<term>Coronavirus Infections (physiopathology)</term>
<term>Female (MeSH)</term>
<term>Humans (MeSH)</term>
<term>Immunotherapy (MeSH)</term>
<term>Incidence (MeSH)</term>
<term>Italy (epidemiology)</term>
<term>Lung (diagnostic imaging)</term>
<term>Lung (pathology)</term>
<term>Male (MeSH)</term>
<term>Middle Aged (MeSH)</term>
<term>Neoplasms (epidemiology)</term>
<term>Neoplasms (therapy)</term>
<term>Pandemics (MeSH)</term>
<term>Pharynx (virology)</term>
<term>Pneumonia, Viral (diagnosis)</term>
<term>Pneumonia, Viral (epidemiology)</term>
<term>Pneumonia, Viral (pathology)</term>
<term>Pneumonia, Viral (physiopathology)</term>
<term>Prospective Studies (MeSH)</term>
<term>Risk Factors (MeSH)</term>
<term>Tomography, X-Ray Computed (MeSH)</term>
</keywords>
<keywords scheme="MESH" type="chemical" qualifier="therapeutic use" xml:lang="en"><term>Antineoplastic Agents, Immunological</term>
</keywords>
<keywords scheme="MESH" type="geographic" qualifier="epidemiology" xml:lang="en"><term>Italy</term>
</keywords>
<keywords scheme="MESH" qualifier="diagnosis" xml:lang="en"><term>Coronavirus Infections</term>
<term>Pneumonia, Viral</term>
</keywords>
<keywords scheme="MESH" qualifier="diagnostic imaging" xml:lang="en"><term>Lung</term>
</keywords>
<keywords scheme="MESH" qualifier="epidemiology" xml:lang="en"><term>Coronavirus Infections</term>
<term>Neoplasms</term>
<term>Pneumonia, Viral</term>
</keywords>
<keywords scheme="MESH" qualifier="isolation & purification" xml:lang="en"><term>Betacoronavirus</term>
</keywords>
<keywords scheme="MESH" qualifier="pathology" xml:lang="en"><term>Coronavirus Infections</term>
<term>Lung</term>
<term>Pneumonia, Viral</term>
</keywords>
<keywords scheme="MESH" qualifier="physiopathology" xml:lang="en"><term>Coronavirus Infections</term>
<term>Pneumonia, Viral</term>
</keywords>
<keywords scheme="MESH" qualifier="therapy" xml:lang="en"><term>Neoplasms</term>
</keywords>
<keywords scheme="MESH" qualifier="virology" xml:lang="en"><term>Pharynx</term>
</keywords>
<keywords scheme="MESH" xml:lang="en"><term>Adult</term>
<term>Aged</term>
<term>Aged, 80 and over</term>
<term>Female</term>
<term>Humans</term>
<term>Immunotherapy</term>
<term>Incidence</term>
<term>Male</term>
<term>Middle Aged</term>
<term>Pandemics</term>
<term>Prospective Studies</term>
<term>Risk Factors</term>
<term>Tomography, X-Ray Computed</term>
</keywords>
</textClass>
</profileDesc>
</teiHeader>
<front><div type="abstract" xml:lang="en"><b>Aim:</b>
Evaluating the incidence and course of COVID-19 in cancer patients treated with immunotherapy. <b>Patients & methods:</b>
We reported the influenza-like illness events with diagnosis of COVID-19 within the patient cohort enrolled in the prospective observational multicenter INVIDIa-2 study in the single center of Parma. <b>Results:</b>
Among 53 patients, eight experienced influenza-like illness during the influenza season 2019/2020, and three of them had diagnosis of COVID-19. They were males, elderly, with cardiovascular disease. Radiological features of COVID-19 pneumonitis were found in all of three cases, although the pharyngeal swab resulted positive in only two. Two of these three patients died due to respiratory failure. <b>Conclusion:</b>
Cancer patients are at high risk of severe events from severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection.</div>
</front>
</TEI>
<pubmed><MedlineCitation Status="MEDLINE" Owner="NLM"><PMID Version="1">32933369</PMID>
<DateCompleted><Year>2020</Year>
<Month>10</Month>
<Day>13</Day>
</DateCompleted>
<DateRevised><Year>2020</Year>
<Month>10</Month>
<Day>13</Day>
</DateRevised>
<Article PubModel="Print-Electronic"><Journal><ISSN IssnType="Electronic">1750-7448</ISSN>
<JournalIssue CitedMedium="Internet"><Volume>12</Volume>
<Issue>15</Issue>
<PubDate><Year>2020</Year>
<Month>10</Month>
</PubDate>
</JournalIssue>
<Title>Immunotherapy</Title>
<ISOAbbreviation>Immunotherapy</ISOAbbreviation>
</Journal>
<ArticleTitle>Clinical impact of COVID-19 in a single-center cohort of a prospective study in cancer patients receiving immunotherapy.</ArticleTitle>
<Pagination><MedlinePgn>1139-1148</MedlinePgn>
</Pagination>
<ELocationID EIdType="doi" ValidYN="Y">10.2217/imt-2020-0211</ELocationID>
<Abstract><AbstractText><b>Aim:</b>
Evaluating the incidence and course of COVID-19 in cancer patients treated with immunotherapy. <b>Patients & methods:</b>
We reported the influenza-like illness events with diagnosis of COVID-19 within the patient cohort enrolled in the prospective observational multicenter INVIDIa-2 study in the single center of Parma. <b>Results:</b>
Among 53 patients, eight experienced influenza-like illness during the influenza season 2019/2020, and three of them had diagnosis of COVID-19. They were males, elderly, with cardiovascular disease. Radiological features of COVID-19 pneumonitis were found in all of three cases, although the pharyngeal swab resulted positive in only two. Two of these three patients died due to respiratory failure. <b>Conclusion:</b>
Cancer patients are at high risk of severe events from severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection.</AbstractText>
</Abstract>
<AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Bersanelli</LastName>
<ForeName>Melissa</ForeName>
<Initials>M</Initials>
<Identifier Source="ORCID">0000-0002-6527-6281</Identifier>
<AffiliationInfo><Affiliation>Medical Oncology Unit, University of Parma, 43126, Parma, Italy.</Affiliation>
</AffiliationInfo>
<AffiliationInfo><Affiliation>Medicine & Surgery Department, University of Parma, Parma, Italy.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y"><LastName>Zielli</LastName>
<ForeName>Teresa</ForeName>
<Initials>T</Initials>
<AffiliationInfo><Affiliation>Medical Oncology Unit, University of Parma, 43126, Parma, Italy.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y"><LastName>Perrone</LastName>
<ForeName>Fabiana</ForeName>
<Initials>F</Initials>
<Identifier Source="ORCID">0000-0001-8090-770X</Identifier>
<AffiliationInfo><Affiliation>Medical Oncology Unit, University of Parma, 43126, Parma, Italy.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y"><LastName>Casartelli</LastName>
<ForeName>Chiara</ForeName>
<Initials>C</Initials>
<AffiliationInfo><Affiliation>Medical Oncology Unit, University of Parma, 43126, Parma, Italy.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y"><LastName>Pratticò</LastName>
<ForeName>Fabiana</ForeName>
<Initials>F</Initials>
<AffiliationInfo><Affiliation>Medicine & Surgery Department, University of Parma, Parma, Italy.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y"><LastName>Rapacchi</LastName>
<ForeName>Elena</ForeName>
<Initials>E</Initials>
<AffiliationInfo><Affiliation>Medical Oncology Unit, University of Parma, 43126, Parma, Italy.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y"><LastName>Camisa</LastName>
<ForeName>Roberta</ForeName>
<Initials>R</Initials>
<AffiliationInfo><Affiliation>Medical Oncology Unit, University of Parma, 43126, Parma, Italy.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y"><LastName>Tognetto</LastName>
<ForeName>Michele</ForeName>
<Initials>M</Initials>
<AffiliationInfo><Affiliation>Medical Oncology Unit, University of Parma, 43126, Parma, Italy.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y"><LastName>Clemente</LastName>
<ForeName>Alberto</ForeName>
<Initials>A</Initials>
<AffiliationInfo><Affiliation>Biostatistics & Clinical Research Unit, Istituto Scientifico Romagnolo per lo Studio e la Cura dei Tumori (IRST) IRCCS, 47014, Meldola, Italy.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y"><LastName>Giannarelli</LastName>
<ForeName>Diana</ForeName>
<Initials>D</Initials>
<AffiliationInfo><Affiliation>Biostatistical Unit, Regina Elena National Cancer Institute, IRCCS, 00144, Rome, Italy.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y"><LastName>Rebuzzi</LastName>
<ForeName>Sara Elena</ForeName>
<Initials>SE</Initials>
<Identifier Source="ORCID">0000-0003-0546-6304</Identifier>
<AffiliationInfo><Affiliation>Medical Oncology Unit, University of Parma, 43126, Parma, Italy.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y"><LastName>Leonetti</LastName>
<ForeName>Alessandro</ForeName>
<Initials>A</Initials>
<Identifier Source="ORCID">0000-0001-5415-6703</Identifier>
<AffiliationInfo><Affiliation>Medical Oncology Unit, University of Parma, 43126, Parma, Italy.</Affiliation>
</AffiliationInfo>
<AffiliationInfo><Affiliation>Medicine & Surgery Department, University of Parma, Parma, Italy.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y"><LastName>Bordi</LastName>
<ForeName>Paola</ForeName>
<Initials>P</Initials>
<AffiliationInfo><Affiliation>Medical Oncology Unit, University of Parma, 43126, Parma, Italy.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y"><LastName>Tiseo</LastName>
<ForeName>Marcello</ForeName>
<Initials>M</Initials>
<AffiliationInfo><Affiliation>Medicine & Surgery Department, University of Parma, Parma, Italy.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y"><LastName>Buti</LastName>
<ForeName>Sebastiano</ForeName>
<Initials>S</Initials>
<Identifier Source="ORCID">0000-0003-0876-0226</Identifier>
<AffiliationInfo><Affiliation>Medical Oncology Unit, University of Parma, 43126, Parma, Italy.</Affiliation>
</AffiliationInfo>
</Author>
</AuthorList>
<Language>eng</Language>
<PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType>
<PublicationType UI="D064888">Observational Study</PublicationType>
</PublicationTypeList>
<ArticleDate DateType="Electronic"><Year>2020</Year>
<Month>09</Month>
<Day>15</Day>
</ArticleDate>
</Article>
<MedlineJournalInfo><Country>England</Country>
<MedlineTA>Immunotherapy</MedlineTA>
<NlmUniqueID>101485158</NlmUniqueID>
<ISSNLinking>1750-743X</ISSNLinking>
</MedlineJournalInfo>
<ChemicalList><Chemical><RegistryNumber>0</RegistryNumber>
<NameOfSubstance UI="D000074322">Antineoplastic Agents, Immunological</NameOfSubstance>
</Chemical>
</ChemicalList>
<SupplMeshList><SupplMeshName Type="Disease" UI="C000657245">COVID-19</SupplMeshName>
<SupplMeshName Type="Organism" UI="C000656484">severe acute respiratory syndrome coronavirus 2</SupplMeshName>
</SupplMeshList>
<CitationSubset>IM</CitationSubset>
<MeshHeadingList><MeshHeading><DescriptorName UI="D000328" MajorTopicYN="N">Adult</DescriptorName>
</MeshHeading>
<MeshHeading><DescriptorName UI="D000368" MajorTopicYN="N">Aged</DescriptorName>
</MeshHeading>
<MeshHeading><DescriptorName UI="D000369" MajorTopicYN="N">Aged, 80 and over</DescriptorName>
</MeshHeading>
<MeshHeading><DescriptorName UI="D000074322" MajorTopicYN="N">Antineoplastic Agents, Immunological</DescriptorName>
<QualifierName UI="Q000627" MajorTopicYN="N">therapeutic use</QualifierName>
</MeshHeading>
<MeshHeading><DescriptorName UI="D000073640" MajorTopicYN="N">Betacoronavirus</DescriptorName>
<QualifierName UI="Q000302" MajorTopicYN="N">isolation & purification</QualifierName>
</MeshHeading>
<MeshHeading><DescriptorName UI="D018352" MajorTopicYN="N">Coronavirus Infections</DescriptorName>
<QualifierName UI="Q000175" MajorTopicYN="N">diagnosis</QualifierName>
<QualifierName UI="Q000453" MajorTopicYN="Y">epidemiology</QualifierName>
<QualifierName UI="Q000473" MajorTopicYN="N">pathology</QualifierName>
<QualifierName UI="Q000503" MajorTopicYN="N">physiopathology</QualifierName>
</MeshHeading>
<MeshHeading><DescriptorName UI="D005260" MajorTopicYN="N">Female</DescriptorName>
</MeshHeading>
<MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName>
</MeshHeading>
<MeshHeading><DescriptorName UI="D007167" MajorTopicYN="Y">Immunotherapy</DescriptorName>
</MeshHeading>
<MeshHeading><DescriptorName UI="D015994" MajorTopicYN="N">Incidence</DescriptorName>
</MeshHeading>
<MeshHeading><DescriptorName UI="D007558" MajorTopicYN="N" Type="Geographic">Italy</DescriptorName>
<QualifierName UI="Q000453" MajorTopicYN="N">epidemiology</QualifierName>
</MeshHeading>
<MeshHeading><DescriptorName UI="D008168" MajorTopicYN="N">Lung</DescriptorName>
<QualifierName UI="Q000000981" MajorTopicYN="N">diagnostic imaging</QualifierName>
<QualifierName UI="Q000473" MajorTopicYN="N">pathology</QualifierName>
</MeshHeading>
<MeshHeading><DescriptorName UI="D008297" MajorTopicYN="N">Male</DescriptorName>
</MeshHeading>
<MeshHeading><DescriptorName UI="D008875" MajorTopicYN="N">Middle Aged</DescriptorName>
</MeshHeading>
<MeshHeading><DescriptorName UI="D009369" MajorTopicYN="N">Neoplasms</DescriptorName>
<QualifierName UI="Q000453" MajorTopicYN="Y">epidemiology</QualifierName>
<QualifierName UI="Q000628" MajorTopicYN="Y">therapy</QualifierName>
</MeshHeading>
<MeshHeading><DescriptorName UI="D058873" MajorTopicYN="N">Pandemics</DescriptorName>
</MeshHeading>
<MeshHeading><DescriptorName UI="D010614" MajorTopicYN="N">Pharynx</DescriptorName>
<QualifierName UI="Q000821" MajorTopicYN="N">virology</QualifierName>
</MeshHeading>
<MeshHeading><DescriptorName UI="D011024" MajorTopicYN="N">Pneumonia, Viral</DescriptorName>
<QualifierName UI="Q000175" MajorTopicYN="N">diagnosis</QualifierName>
<QualifierName UI="Q000453" MajorTopicYN="Y">epidemiology</QualifierName>
<QualifierName UI="Q000473" MajorTopicYN="N">pathology</QualifierName>
<QualifierName UI="Q000503" MajorTopicYN="N">physiopathology</QualifierName>
</MeshHeading>
<MeshHeading><DescriptorName UI="D011446" MajorTopicYN="N">Prospective Studies</DescriptorName>
</MeshHeading>
<MeshHeading><DescriptorName UI="D012307" MajorTopicYN="N">Risk Factors</DescriptorName>
</MeshHeading>
<MeshHeading><DescriptorName UI="D014057" MajorTopicYN="N">Tomography, X-Ray Computed</DescriptorName>
</MeshHeading>
</MeshHeadingList>
<KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="Y">COVID-19</Keyword>
<Keyword MajorTopicYN="Y">SARS-CoV2</Keyword>
<Keyword MajorTopicYN="Y">anti-PD-1</Keyword>
<Keyword MajorTopicYN="Y">cancer patients</Keyword>
<Keyword MajorTopicYN="Y">immune checkpoint inhibitors</Keyword>
<Keyword MajorTopicYN="Y">immunotherapy</Keyword>
<Keyword MajorTopicYN="Y">influenza vaccine</Keyword>
<Keyword MajorTopicYN="Y">interstitial pneumonia</Keyword>
</KeywordList>
</MedlineCitation>
<PubmedData><History><PubMedPubDate PubStatus="pubmed"><Year>2020</Year>
<Month>9</Month>
<Day>17</Day>
<Hour>6</Hour>
<Minute>0</Minute>
</PubMedPubDate>
<PubMedPubDate PubStatus="medline"><Year>2020</Year>
<Month>9</Month>
<Day>17</Day>
<Hour>6</Hour>
<Minute>0</Minute>
</PubMedPubDate>
<PubMedPubDate PubStatus="entrez"><Year>2020</Year>
<Month>9</Month>
<Day>16</Day>
<Hour>5</Hour>
<Minute>27</Minute>
</PubMedPubDate>
</History>
<PublicationStatus>ppublish</PublicationStatus>
<ArticleIdList><ArticleId IdType="pubmed">32933369</ArticleId>
<ArticleId IdType="doi">10.2217/imt-2020-0211</ArticleId>
<ArticleId IdType="pmc">PMC7493722</ArticleId>
</ArticleIdList>
<ReferenceList><Reference><Citation>Cancer Discov. 2020 Jun;10(6):783-791</Citation>
<ArticleIdList><ArticleId IdType="pubmed">32345594</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>Euro Surveill. 2017 Apr 6;22(14):</Citation>
<ArticleIdList><ArticleId IdType="pubmed">28422004</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>Radiology. 2020 Apr;295(1):202-207</Citation>
<ArticleIdList><ArticleId IdType="pubmed">32017661</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>Euro Surveill. 2020 Jan;25(3):</Citation>
<ArticleIdList><ArticleId IdType="pubmed">31992387</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>J Thorac Imaging. 2020 Jul;35(4):228-233</Citation>
<ArticleIdList><ArticleId IdType="pubmed">32271278</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>Lancet. 2020 Mar 28;395(10229):1054-1062</Citation>
<ArticleIdList><ArticleId IdType="pubmed">32171076</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>Am J Hematol. 2020 Jul;95(7):834-847</Citation>
<ArticleIdList><ArticleId IdType="pubmed">32282949</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>JAMA Oncol. 2020 Jul 1;6(7):1108-1110</Citation>
<ArticleIdList><ArticleId IdType="pubmed">32211820</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>Eur J Cancer. 2020 Jun;132:199-206</Citation>
<ArticleIdList><ArticleId IdType="pubmed">32380430</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>J Autoimmun. 2020 May;109:102433</Citation>
<ArticleIdList><ArticleId IdType="pubmed">32113704</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>Immunotherapy. 2020 Feb;12(2):105-110</Citation>
<ArticleIdList><ArticleId IdType="pubmed">32046555</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>Science. 2018 Mar 23;359(6382):1350-1355</Citation>
<ArticleIdList><ArticleId IdType="pubmed">29567705</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>JAMA. 2020 May 12;323(18):1843-1844</Citation>
<ArticleIdList><ArticleId IdType="pubmed">32159775</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>Nat Rev Clin Oncol. 2020 Jul;17(7):386-388</Citation>
<ArticleIdList><ArticleId IdType="pubmed">32424196</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>Immunotherapy. 2020 Jun;12(8):541-544</Citation>
<ArticleIdList><ArticleId IdType="pubmed">32345093</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>Eur Arch Otorhinolaryngol. 2020 Jun 17;:</Citation>
<ArticleIdList><ArticleId IdType="pubmed">32556781</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>Ann Oncol. 2020 Jul;31(7):894-901</Citation>
<ArticleIdList><ArticleId IdType="pubmed">32224151</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>Lancet. 2020 Jun 20;395(10241):1919-1926</Citation>
<ArticleIdList><ArticleId IdType="pubmed">32473682</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>J Infect. 2020 Aug;81(2):e16-e25</Citation>
<ArticleIdList><ArticleId IdType="pubmed">32335169</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>Eur Urol. 2020 Aug;78(2):276-280</Citation>
<ArticleIdList><ArticleId IdType="pubmed">32534910</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>BMJ. 2020 Mar 26;368:m1091</Citation>
<ArticleIdList><ArticleId IdType="pubmed">32217556</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>Immunotherapy. 2020 Apr;12(5):269-273</Citation>
<ArticleIdList><ArticleId IdType="pubmed">32212881</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>Lancet Oncol. 2020 Jul;21(7):914-922</Citation>
<ArticleIdList><ArticleId IdType="pubmed">32539942</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>Int J Antimicrob Agents. 2020 May;55(5):105951</Citation>
<ArticleIdList><ArticleId IdType="pubmed">32234466</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>Radiology. 2020 Apr;295(1):20</Citation>
<ArticleIdList><ArticleId IdType="pubmed">32032497</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>Clin Chem. 2020 Apr 1;66(4):549-555</Citation>
<ArticleIdList><ArticleId IdType="pubmed">32031583</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>JAMA. 2020 Aug 14;:</Citation>
<ArticleIdList><ArticleId IdType="pubmed">32797145</ArticleId>
</ArticleIdList>
</Reference>
</ReferenceList>
</PubmedData>
</pubmed>
</record>
Pour manipuler ce document sous Unix (Dilib)
EXPLOR_STEP=$WICRI_ROOT/Sante/explor/CovidSeniorV1/Data/Main/Corpus
HfdSelect -h $EXPLOR_STEP/biblio.hfd -nk 000204 | SxmlIndent | more
Ou
HfdSelect -h $EXPLOR_AREA/Data/Main/Corpus/biblio.hfd -nk 000204 | SxmlIndent | more
Pour mettre un lien sur cette page dans le réseau Wicri
{{Explor lien |wiki= Sante |area= CovidSeniorV1 |flux= Main |étape= Corpus |type= RBID |clé= pubmed:32933369 |texte= Clinical impact of COVID-19 in a single-center cohort of a prospective study in cancer patients receiving immunotherapy. }}
Pour générer des pages wiki
HfdIndexSelect -h $EXPLOR_AREA/Data/Main/Corpus/RBID.i -Sk "pubmed:32933369" \ | HfdSelect -Kh $EXPLOR_AREA/Data/Main/Corpus/biblio.hfd \ | NlmPubMed2Wicri -a CovidSeniorV1
![]() | This area was generated with Dilib version V0.6.37. | ![]() |